MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine
*Biotechnology: Key Issues
*Key Terms: Biotechnology
Assay
Parents
*Key Terms: Biotechnology
BioTechnology
Children
- Clonogenic High-Throughput Assay for Screening Anti-Cancer Agents and Radiation Modulators
- Development of POC Assays to Quantify anti-Tuberculosis Antibiotics in Blood
- Development of Sample Sparing Assay
- Virology Assays, Including Plaque Assays, Media Formulation, Method Development, as Well as Molecular Virology Services
* Multiplex Cytokine Assay
* Point-of-Care diagnostic assays for SARS-CoV-2 virus :
*Architects: Biomaterials (Miscellaneous _ Assays, Reagents & Diagnostics)
*Assay technologies are used to make such isolated bio-molecules visible.
*Clinical-stage medical device company focused on next-generation multiplexing technology, hardware and software for antibody, protein and nucleic acid assays for autoimmune diseases and other diseases
*Diagnostic assay to detect COVID-19 disease
*Diagnostic assays for human pan-coronaviruses
*Leading global provider of sample and assay technologies.
*QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables.
*QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
*T2’s lead product is a rapid detection assay for Candida, a fungal pathogen known to cause blood stream infections and sepsis.
*The company is pursuing a strategy over the next several years to aggregate all the world's medical genetic tests (>3,000 known Mendelian inherited conditions) into a single assay at a lower cost than most single gene tests
*With the improved workflow, the assay can be performed without an instrument for reading and does not require any specialized equipment.
2008: Biochemical-Based Assays for HTS May 13-15, 2008 • Philadelphia, PA
2011: Commercial-stage a protein analysis, biomaterial manufacturing and biodiscovery assay kit developer, closed a$65M Series E financing (2011).
2014: NSF-14-539 - SBIR (Small Business Innovation Research Program) - June 10, 2014: BM6. Diagnostic Assays and Platforms
2014: QIAGEN Adds Promising New Biomarker to Pipeline of Personalized Healthcare Assays to Improve Diagnosis of Blood Disorders
2017: CDC_Malaria Biomarker Assay Project
2017: NIH-PA-14-101: Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R43/R44) = $1,250,000 - Letter of Intent Due Date(s): April 5, August 5, December 5 , Expiration Date: January 8, 2017
2017: NIH-PA-14-102: Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42) = $1,250,000 - Letter of Intent Due Date(s): April 5, August 5, December 5 , Expiration Date: January 8, 2017
2018: A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS
2018: MTEC-18-06-Cryopreserved Platelet (CPP) Solicitation
2018: Quadrant Biosciences Awarded $2 Million NIH Grant for Novel Autism Spectrum Disorder Diagnostic Assay
2019: U.S. Army_Development of a Traumatic Brain Injury (TBI) Diagnostic Assay for the i-STAT_Abbot
2020: Awarded a $12,674,104 cost-plus-fixed-fee contract to develop a flexible detection system consisting of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based assays paired with reconfigurable point-of-need and massively multi-plexed devices for diagnostics and surveillance.
2020: FDA ranks the performance of 58 molecular coronavirus tests from major developers
2020: Hologic Awarded $13M from BARDA to Develop Second Coronavirus Assay
2021: NASEM Panel_DRUG RESEARCH AND DEVELOPMENT FOR ADULTS ACROSS THE OLDER AGE SPAN
2021: NIH_NOIP_Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24)
2021: NINDS_NOIP_Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
2026: NCI _Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
A portable mini-lab that can rapidly perform multiple RT-PCR assays in a single platform.
A portable mini-lab that can rapidly perform multiple RT-PCR assays in a single platform.
A series of novel diagnostic assays for the cardiovascular and cerebrovascular market.
Accord Biomaterials, Inc., based in Ann Arbor, MI, focuses upon the development of NogenTM nitric oxide materials for use in biomarker assays, diagnostic tools and blood-contacting medical devices.
An Assay for Detecting Variant Hepatitis B Viruses-The Pennsylvania State University
An Assay for Screening/Ranking Antioxidants Based on Their Effects on Membrane Sterol Lateral Organization-Temple University
Antibody binding assay (IC50/EC50 determination)
Assay Biomarker Inc.
Assay Biomarker Inc. and Bingren Hu, professor, University of Maryland, Baltimore ($147,525): developing glycoform-specific antibodies for detecting cancer biomarkers.
Assay Depot Raises $1.7M to Expand Online Commerce for Biotech Industry
Assay Depot-the worlds largest online marketplace for outsourced pharmaceutical research services
Assay for Quantifiying Botulinum Toxins-USAMRMC
assay indicating arginine deficiency
assays developed here will be in place for rapid high-throughput detection
Assays for the Effect of Protease Inhibitors on the Glut4 Glucose Transporter-Washington University in St. Louis
Assays to detect E. coli, Salmonella, Campylobacter, and Listeria pathogens are under development.
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays for $270 million (2009)
Biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics wit
Biotech company specialized in research & development, production and marketing in the field of immunochromatographic assay and immunofluorescence assay
blood and spleens will be used in immunological assays,
Burning Rock was founded to develop a proprietary cancer screening and therapy selection system utilizing tissue and liquid biopsies, assay biochemistry, genetic databases and bioinformatics to provide decision support services to oncologists in China.
CADDMR Technology, Providing a Cell-Based Assay for Drug Discovery for Mental Retardation Disorders-University of Arizona
Commercial products and products in its near-term pipeline include rapid sample preparation methodologies for nucleic acid extraction and multiplex panel assays for detecting multidrug-resistant tuberculosis (MDR-TB), upper respiratory infections, viral en
Commercial-stage biotechnology assay company focused on analysis of signal transduction pathways and target validation
Consolidators: Laboratory Equipment, Testing, Information Systems, Reagents & Assays
Custom setup/assay
Demonstrate and validate the usefulness of this assay
Develop high throughput screening assay for id of small molecule agents for osteogenic therapy
Develop means to test multiple genes in a functional assay
Developed a novel in vitro assay to identify chemicals that can damage the DNA of mammalian cells
Development of the assays proposed here will facilitate spatial and kinetic measurement of toxin and other virulence gene expres
Development-stage biotechnologycompany focused on an open platform multiplexed biological assay standardization for the quantification of biological function
Development-stage diagnostic company focused on molecular assays for monitoring food safety applications and biopharmaceutical manufacturing
DHA_Industry Day 2019_Key_Note_Speaker_Brief
Diagnostic assay for detection of COVID-19 disease
DiaTech uses a technology called the Microculture Kinetic (MiCK) assay®, which measures apoptosis (cell death) induced in a specific patient's cancer cells by chemotherapy.
Dip-stick Assay for C-reactive Protein
drug profiling, novel 2D & 3D phenotypic assays, tumor microenvironment studies, and responsive-patient prediction.
Drug screening technology using proprietary apoptosis assays
Each assay the company develops could have multiple applications, rather than just one like some other molecular diagnostic companies
Engaged in the Development of Biomarker-based in Vitro Diagnostic Assays for Cancer
Enzo Life Sciences, Inc. (formerly Assay Designs, Inc.)
Epigenomics, Wuhan Kindstar Ink Deal for Lung Cancer Assay in China (2014)
First commercial product, due out in 2015, will be the Q-POC™, QuantuMDx’s hand-held point of care platform, with first commercial assays in companion diagnostics and multi-drug resistant infectious disease testing (including TB, HIV and STIs).
French developer of cell-based assays, has raised $10 million in Series C funding.
GENETIC ASSAY TO PREDICT ALZHEIMERíS DISEASE FOLLOWING TRAUMATIC BRAIN INJURY-University of Pennsylvania
High Throughput In Vivo Dynamic Metabolic Assay Using an Embryonic Development Model-University of Arizona
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis
Ichor has also developed novel immune screening assays, which enable the rapidly profiling of protective immune responses.
In addition, Zyomyx provides a product line of human and murine cytokine protein assays to customers using a streamlined service
Infectious Myonecrosis Virus (IMNV) Nucleotide Sequence, Primers for RT-PCR and a DNA Probe for In Situ Hybridization Assays for Detection of the Virus in Shrimp-University of Arizona
IQuum Receives NIAID Fast Track Grant for Development of Rapid Point-of-Care Diagnostic Assay for Pandemic Influenza (2010)
Its product lines include: flow cytometers, cell imaging systems, monoclonal antibodies, research reagents, diagnostic assays, a
Its RaDaR assay in the detection of MRD in early-stage cancer patients.
lateral flow immunochromatography (LFI), enzyme linked Immunosorbant assay (ELISA), optical immunoassays (OIA) and polymerase ch
Lyme Disease Assay-University of California System: University of California, Davis
Makes the AssayMAP Microchromatography platform
Megellan Biosciences thru its subsidiaries, designs and commercializes point-of-care analyzers, automated clinical-assay workstations, diagnostic systems and assays, and related consumables and services for hospital-based labs and near-patient testing.
Micronics' patented microfluidics and microplumbing technologies, coupled with its expertise in integrating molecular and immunoassays on card, allow it to fundamentally modify the way in which fluids are processed and diagnostic assays are performed at gr
Microvisk Technologies (United Kingdom) a clinical-stage diagnostic company focused on prothrombin time assays designed to provide patients and clinicians with INR values used to aid in the correct dosage of anti-coagulation meds such as warfarin
MightyLight Rluc Assay Kit
Molecular diagnostic assay for SARS-CoV-2 virus on existing FDA-cleared platform
Molecular diagnostic assays for infectious diseases, with an initial focus on hospital-acquired infections
New CEO leads expansion of personalized medicine dosing assay company
NLS offers services in pharmacology, disease models, early safety assessments, toxicology, PCR, Flow Cytometry, in vivo imaging, and cell-based assays
Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an individual's tumor or disease.
Offers state-of-the-art assay technology for infectious disease diagnosis and pathogen detection
Olink was founded to develop its Proximity Extension Assay technology enabling researchers 'to use one platform from discovery to clinical trials to diagnostic applications utilizing a significant, established infrastructure of labs and installed instrumentation
optimized quantitative polymerase chain reaction (PCR) assays for the B. anthracis genes
OvaDx presymptomatic diagnostic assay for ovarian cancer
p53 Induction as a Genotoxicity Assay-NMTB
Patent-pending assays using synthetic DNA and functional conjugate molecules (Oligofluors) in a handheld reader system
Point-of-care diagnostic assay for detection of SARS-CoV-2 virus
Pronucleotein’s pathogen assays use aptamers, magnetic beads, and/or fluorescence components to detect food and waterborne microorganisms at the point of testing.
Proprietary, single-step Touch Activated Phlebotomy™ (TAP™) technology can be combined with a variety of diagnostic assays for rapid results.
Q3DM provides High Throughput Microscopy (HTM) platforms and optimized assays focused on alleviating substantial inefficiencies
Real-Time Blood Assay - CIMIT
Receptor-ligand assay for orphan tyrosine kinase receptors-Harvard University Office of Technology Development
SABiosciences holds a leading position in the design and commercialization of disease- and pathway-focused real-time PCR-based assay panels ("PCR Arrays")
San Diego’s Assay Depot Creates Private e-Commerce Sites for Pfizer, Other Big Pharmas (2011)
Serve proteomics/bioinformatics needs/assays for researchers in Western Pennsylvania region.
Skin physiology, skin/device interface, and novel assay development, Seventh Sense is creating a unique "On Vivo™" blood sampling and testing platform.
The company produces and markets a range of infectious disease assay kits and instruments.
The company's primary product family includes more than 100 real-time PCR assay panels designed for high-performance analysis of DNA, RNA, epigenetic and microRNA targets in biological pathways associated both with specific diseases such as cancer, diabete
The contract will fund the further development of an assay to identify and characterize circulating tumor cells (CTCs) in lung cancer patients.
The Mammoth Biosciences SARS-CoV-2 DETECTR assay uses CRISPR technology, which provides a simpler workflow and significantly faster turnaround time compared to conventional laboratory PCR tests.
The tests employ existing chemical assays to detect infections or other issues using urine samples or a throat swab.
Thermal Stability Assay for Glaucoma-Causing Myocilin Mutants and Method to Screen for Small Molecule Stabilizers-Georgia Tech Research Corporation
This non-invasive assay platform has been validated to detect all four major types of genetic alterations known to drive cancers.
TruGenomix is a precision behavioral health company advancing the diagnosis and treatment of PTSD through TruGen-1, a patented genomic biomarker assay, and the TruGenomix Platform, an evidence-based decision support tool.
Two assays for measuring alterations in platelet function by anti-platelet agents (including aspirin and Plavix®) have been clea
Use NCI60 Proteomic & Chemo-Assay Database
VBI has developed a series of new 3-D or tissue-like assay models for rapid analysis of drug efficacy, toxicity and therapeutic
Velox™ is a highly novel molecular diagnostic system for the ultra-rapid diagnosis of a broad range of infectious diseases using either nucleic acid or immuno-assays.